Recent studies indicated that ME2 was dysregulated in several tumors and serves as a target in the regulation of tumor proliferation, differentiation, metabolism, and invasion in various cancers, such as lung cancer, pancreatic cancer, and erythroleukemia.12, 17, 18. The gene discussed is ME2; the disease is familial pancreatic carcinoma.